James Barrow

Dr. James Barrow

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2014 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
NCNicholas E. Calcaterra
Nicholas E. Calcaterra
JBJames Barrow
James Barrow

1 July 2000 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JBJames Barrow
James Barrow
PNPhilippe G. Nantermet
Philippe G. Nantermet
HSHarold G. Selnick
Harold G. Selnick
KGKristen L. Glass
Kristen L. Glass
KRKenneth E. Rittle
Kenneth E. Rittle
CFCarlos Forray
Carlos Forray

10 June 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WSWilliam D. Shipe
William D. Shipe
JBJames Barrow
James Barrow
ZYZhi-Qiang Yang
Zhi-Qiang Yang
CLCraig W. Lindsley
Craig W. Lindsley
FYF. Vivien Yang
F. Vivien Yang
JRJohn J. Renger
John J. Renger

26 May 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
LCLaureen Colis
Laureen Colis
KPKarita Peltonen
Karita Peltonen
PSPaul Sirajuddin
Paul Sirajuddin
HLHester Liu
Hester Liu
SSSara Sanders
Sara Sanders
MLMarikki Laiho
Marikki Laiho
DNA intercalation is a major therapeutic modality for cancer therapeutic drugs. The therapeutic activity comes at a cost of normal tissue toxicity and genotoxicity. We have recently described a planar heterocyclic small molecule DNA intercalator, BMH-21, that binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription. Despite DNA intercalation, BMH-21 does not cause phosphorylation of H2AX, a key biomarker activated in DNA damage stress. Here we assessed whether BMH-21 activity towards expression and localization of Pol I marker proteins depends on DNA damage signaling and repair pathways. We show that BMH-21 effects on the nucleolar stress response were independent of major DNA damage associated PI3-kinase pathways, ATM, ATR and DNA-PKcs. However, testing a series of BMH-21 derivatives with alterations in its N,N-dimethylaminocarboxamide arm showed that several derivatives had acquired the property to activate ATM- and DNA-PKcs -dependent damage sensing and repair pathways while their ability to cause nucleolar stress and affect cell viability was greatly reduced. The data show that BMH-21 is a chemically unique DNA intercalator that has high bioactivity towards Pol I inhibition without activation or dependence of DNA damage stress. The findings also show that interference with DNA and DNA metabolic processes can be exploited therapeutically without causing DNA damage.

1 April 2014 in Molecular Cell
Verified
Journal Article
Closed access
FRFeng Rao
Feng Rao
JCJiyoung Cha
Jiyoung Cha
JXJing Xu
Jing Xu
RXRisheng Xu
Risheng Xu
MVM. Scott Vandiver
M. Scott Vandiver
SSSolomon H. Snyder
Solomon H. Snyder

8 January 2003 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CBChristopher S. Burgey
Christopher S. Burgey
KRKyle A. Robinson
Kyle A. Robinson
TLTerry A. Lyle
Terry A. Lyle
PSPhilip E. J. Sanderson
Philip E. J. Sanderson
SLS. Dale Lewis
S. Dale Lewis
JVJoseph P. Vacca
Joseph P. Vacca